Ketoprofen and Rash for Men aged 30-39 (a phase IV clinical study of FDA data)

Summary:

Rash is found for men aged 30-39 who take Ketoprofen (ketoprofen). This study is created by eHealthMe based on reports of 404 men aged 30-39 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

Time on Ketoprofen when people have Rash
Top conditions
Top co-used drugs
Top other side effects

On Jul, 04, 2026

404 men aged 30-39 reported to have side effects when taking Ketoprofen.
Among them, 18 people (4.46%) have Rash

What is Ketoprofen?

Ketoprofen has active ingredients of ketoprofen. It is often used in pain. eHealthMe is studying from 15,048 Ketoprofen users. Check the latest studies of Ketoprofen.

What is Rash?

Rash is found to be associated with 3,973 drugs and 6,220 conditions by eHealthMe. Check the latest studies of Rash.

Number of reports submitted per year:

Could Ketoprofen cause Rash in men aged 30-39?

Time on Ketoprofen when people have Rash *

Severity of Rash

n/a

How people recovered from Rash

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

Pulpitis Dental (inflammation of the tooth pulp): 3 people, 16.67%
Mental Disability: 2 people, 11.11%
Toothaches (tooth pain): 1 person, 5.56%
Pharyngitis (inflammation of the pharynx, causing a sore throat): 1 person, 5.56%
Oropharyngeal Pain: 1 person, 5.56%
Juvenile Arthritis (arthritis-related condition that develops in children or teenagers): 1 person, 5.56%
Infection: 1 person, 5.56%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 5.56%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 1 person, 5.56%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

Oedema (fluid collection in tissue): 4 people, 22.22%
Dyspnea (difficult or laboured breathing): 3 people, 16.67%
Urticaria (rash of round, red welts on the skin that itch intensely): 3 people, 16.67%
Nausea (feeling of having an urge to vomit): 3 people, 16.67%
Angioedema (rapid swelling of the dermis): 2 people, 11.11%
Laryngeal Oedema (swelling of larynx): 2 people, 11.11%
Rash Pruritic (redness with itching): 2 people, 11.11%
Rash Erythematous (redness of the skin): 2 people, 11.11%
Pruritus Generalised (generalized itching): 2 people, 11.11%
Eyelid Oedema (eyelids are swollen and contain excessive fluid): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Ketoprofen and have Rash?

- Check whether Rash is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related publications that referenced our studies:

Mohammad MM, Syrigos KN, Saif MW, "Association between Rash and a Positive Drug Response Associated with Vinorelbine in a Patient with Primary Peritoneal Carcinoma", Case reports in dermatological medicine, 2013 Sep .
Mohammad MM, Syrigos KN, Saif MW, "Association between Rash and a Positive Drug Response Associated with Vinorelbine in a Patient with Primary Peritoneal Carcinoma", Case reports in dermatological medicine, 2013 Sep .

Related studies:

Ketoprofen and Rash

How the study uses the data?

The study is based on (applicable) gender, age, ketoprofen (the active ingredients of Ketoprofen) and Ketoprofen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.